Histogen completes A round, planning B round

Regenerative medicine company Histogen Inc. (San Diego, Calif.) plans to raise up to $23 million in a series B round after completing a $10 million series A round. The company raised $5.4 million in an initial close of the A round in 2008. Investors in the round included Secure Medical Inc.; Lordship Ventures; and individual investors. ...